RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung reveals unique pathway regulation

P Sivakumar, JR Thompson, R Ammar… - ERJ open …, 2019 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF), the scarring of lung parenchyma resulting in the loss of
lung function, remains a fatal disease with a significant unmet medical need. Patients with …

[HTML][HTML] Complex involvement of the extracellular matrix, immune effect, and lipid metabolism in the development of idiopathic pulmonary fibrosis

W Qian, S Xia, X Yang, J Yu, B Guo, Z Lin… - Frontiers in Molecular …, 2022 - frontiersin.org
Background and objective: Idiopathic pulmonary fibrosis (IPF) is an aggressive fibrotic
pulmonary disease with spatially and temporally heterogeneous alveolar lesions. There are …

[HTML][HTML] Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis

P Sivakumar, R Ammar, JR Thompson, Y Luo… - Respiratory …, 2021 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with a significant
unmet medical need. Development of transformational therapies for IPF is challenging in …

[HTML][HTML] Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF)

K Boon, NW Bailey, J Yang, MP Steel, S Groshong… - PloS one, 2009 - journals.plos.org
Background Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic interstitial lung
disease that is unresponsive to current therapy and often leads to death. However, the rate …

Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis

LM Kraven, AR Taylor, PL Molyneaux, TM Maher… - Thorax, 2023 - thorax.bmj.com
Background Considerable clinical heterogeneity in idiopathic pulmonary fibrosis (IPF)
suggests the existence of multiple disease endotypes. Identifying these endotypes would …

[HTML][HTML] Impact of transcriptomics on our understanding of pulmonary fibrosis

M Vukmirovic, N Kaminski - Frontiers in medicine, 2018 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a lethal fibrotic lung disease characterized by aberrant
remodeling of the lung parenchyma with extensive changes to the phenotypes of all lung …

[HTML][HTML] Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression

P Ruan, JL Todd, H Zhao, Y Liu, R Vinisko… - Respiratory …, 2023 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is characterized by the accumulation of
extracellular matrix in the pulmonary interstitium and progressive functional decline. We …

[HTML][HTML] A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis

Y Huang, SF Ma, R Vij, JM Oldham… - BMC pulmonary …, 2015 - Springer
Background The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is
highly heterogeneous. Prognostic models rely on demographic and clinical characteristics …

Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes

DJ Kass, N Kaminski - Clinical and translational science, 2011 - Wiley Online Library
A little more than 10 years ago, the completed sequencing of the human genome boldly
promised to usher in an era of enhanced understanding and accelerated development of …

[HTML][HTML] Detecting the molecular system signatures of idiopathic pulmonary fibrosis through integrated genomic analysis

I Gangwar, N Kumar Sharma, G Panzade, S Awasthi… - Scientific reports, 2017 - nature.com
Abstract Idiopathic Pulmonary Fibrosis (IPF) is an incurable progressive fibrotic disease of
the lungs. We currently lack a systematic understanding of IPF biology and a systems …